Comparative analysis of immunological biomarkers in COVID-19 and bacterial pneumonia

Comparative analysis of immunological biomarkers in COVID-19 and bacterial pneumonia

Coronavirus disease 2019 (COVID-19) is a severe and infectious respiratory condition caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This case-control study aimed to evaluate serum levels of various immunological markers in patients with COVID-19 compared to those with ba...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicine and life Vol. 16; no. 12; pp. 1844 - 1851
Main Authors: Abakar, Mudathir Abdelshafea Abdelkareem, Hamad, Daralnaeem Hassan Ali, Faisal, Eman, Omer, Hashim Mohamed Fad-Alla, Faki, Mahmoud Taha Mohamed, Idris, Abdellla Esmail Mohammed, Omer, Rouwida, Osman, Zeinab, Elhassan, Entesar Ahmed Gaffar, Abrahim-Holie, Mohamed Ahmed, Hakami, Mohammed Ageeli, Alghamdi, Abdullah, Alfahed, Abdulaziz, Aloraini, Ghfren Suliman, Alharthi, Nahed Sail, Waggiallah, Hisham Ali
Format: Journal Article
Language:English
Published: Romania Carol Daila University Foundation 01-12-2023
Carol Davila University Press
Subjects:
Adult
Biomarkers
C-Reactive Protein
Case-Control Studies
Chlamydia
Comparative analysis
COVID-19
Cytokines
Data analysis
Humans
Immunology
Interleukin-10
Interleukin-12
Interleukin-8
Lung cancer
Mortality
Original
Patients
Pneumonia
Pneumonia, Bacterial
Proteins
Reagents
Respiratory diseases
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Streptococcus infections
Tumor Necrosis Factor-alpha
Tumor necrosis factor-TNF
C3
COVID-19
CRP
C4
IFN-γ
TNF-α
bacterial pneumonia
IL-12
IL-8
IL-10
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Coronavirus disease 2019 (COVID-19) is a severe and infectious respiratory condition caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This case-control study aimed to evaluate serum levels of various immunological markers in patients with COVID-19 compared to those with bacterial pneumonia and a healthy control group. Serum samples were collected from adult participants across various COVID-19 isolation centers, including Kassala State and Ahmed Gasim Hospital, between April and June 2021. The study included 70 patients diagnosed with COVID-19, 30 with bacterial pneumonia, and 50 healthy controls. Serum levels of C-reactive protein (CRP), complement components C3 and C4, and cytokines IL-8, IL-10, IL-12, TNF-α, and IFN-γ were measured using standard reagent kits. Serum level of CRP was significantly elevated in both bacterial pneumonia and COVID-19 but significantly higher among patients with bacterial pneumonia. C3 and C4 were also increased in both patient groups, with C3 significantly higher in bacterial pneumonia. IL-8, IL-10, IL-12, TNF-α, and IFN-γ were significantly increased in bacterial pneumonia and SARS-Cov-2 compared to healthy controls. However, IFN-γ was significantly increased among patients with COVID-19 than patients with bacterial pneumonia. This study highlights the potential significant impact of COVID-19 on the immunological biomarkers investigated.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1844-3117
1844-122X
1844-3117
DOI:10.25122/jml-2023-0273